Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

Overview

Yoseph Shaaltiel made an average of $616.5K in compensation at Protalix BioTherapeutics from 2006 to 2018.

Annual data

2018

In 2018, Yoseph Shaaltiel earned a total compensation of $433.4K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking9,779 out of 10,998
Percentile11.1%

Yoseph Shaaltiel's 2018 compensation ranked 9,779th out of 10,998 executive pay records tracked by us this year.

Shaaltiel earned more than 11.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,176 out of 1,265
Percentile7.0%

In the industry group of Drugs, Shaaltiel's pay ranked 1,176th out of 1,265 executive pay records tracked by us in 2018.

Shaaltiel earned more than 7.0% of executives in this group.

Option Awards$60,575
Salary$288,719
Other$84,148
Total$433,442

Shaaltiel received $288.7K in salary, which accounts for 66.61% of total compensation.

Shaaltiel also received $60.6K in option awards and $84.1K in other compensation.

Yoseph Shaaltiel's Pay$433,442
Median Employee's Pay$47,782
Pay Ratio9 : 1

For fiscal year 2018, the annual total compensation for Yoseph Shaaltiel was $433,442 and for the median employee at Protalix BioTherapeutics was $47,782. The resulting ratio of Yoseph Shaaltiel's pay to the pay of median employee was 9 to one.

2017

In 2017, Yoseph Shaaltiel earned a total compensation of $472.7K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking11,377 out of 13,798
Percentile17.5%

Yoseph Shaaltiel's 2017 compensation ranked 11,377th out of 13,798 executive pay records tracked by us this year.

Shaaltiel earned more than 17.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,319 out of 1,568
Percentile15.9%

In the industry group of Drugs, Shaaltiel's pay ranked 1,319th out of 1,568 executive pay records tracked by us in 2017.

Shaaltiel earned more than 15.9% of executives in this group.

Bonus$62,176
Option Awards$41,454
Salary$288,326
Other$80,786
Total$472,742

Shaaltiel received $288.3K in salary, which accounts for 60.99% of total compensation.

Shaaltiel also received $62.2K in bonus, $41.5K in option awards and $80.8K in other compensation.

2016

In 2016, Yoseph Shaaltiel earned a total compensation of $465.1K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking11,414 out of 14,043
Percentile18.7%

Yoseph Shaaltiel's 2016 compensation ranked 11,414th out of 14,043 executive pay records tracked by us this year.

Shaaltiel earned more than 18.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,267 out of 1,500
Percentile15.5%

In the industry group of Drugs, Shaaltiel's pay ranked 1,267th out of 1,500 executive pay records tracked by us in 2016.

Shaaltiel earned more than 15.5% of executives in this group.

Option Awards$103,279
Salary$270,248
Stock Awards$18,211
Other$73,325
Total$465,063

Shaaltiel received $270.2K in salary, which accounts for 58.11% of total compensation.

Shaaltiel also received $103.3K in option awards, $18.2K in stock awards and $73.3K in other compensation.

2015

In 2015, Yoseph Shaaltiel earned a total compensation of $653.5K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking9,777 out of 13,589
Percentile28.1%

Yoseph Shaaltiel's 2015 compensation ranked 9,777th out of 13,589 executive pay records tracked by us this year.

Shaaltiel earned more than 28.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,094 out of 1,485
Percentile26.3%

In the industry group of Drugs, Shaaltiel's pay ranked 1,094th out of 1,485 executive pay records tracked by us in 2015.

Shaaltiel earned more than 26.3% of executives in this group.

Bonus$85,000
Option Awards$112,497
Salary$271,730
Stock Awards$110,244
Other$74,058
Total$653,529

Shaaltiel received $271.7K in salary, which accounts for 41.58% of total compensation.

Shaaltiel also received $85K in bonus, $112.5K in option awards, $110.2K in stock awards and $74.1K in other compensation.

2014

In 2014, Yoseph Shaaltiel earned a total compensation of $775.9K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking8,621 out of 12,932
Percentile33.3%

Yoseph Shaaltiel's 2014 compensation ranked 8,621st out of 12,932 executive pay records tracked by us this year.

Shaaltiel earned more than 33.3% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking846 out of 1,316
Percentile35.7%

In the industry group of Drugs, Shaaltiel's pay ranked 846th out of 1,316 executive pay records tracked by us in 2014.

Shaaltiel earned more than 35.7% of executives in this group.

Bonus$90,000
Option Awards$62,651
Salary$305,548
Stock Awards$232,979
Other$84,719
Total$775,897

Shaaltiel received $305.5K in salary, which accounts for 39.38% of total compensation.

Shaaltiel also received $90K in bonus, $62.7K in option awards, $233K in stock awards and $84.7K in other compensation.

2013

In 2013, Yoseph Shaaltiel earned a total compensation of $1.1M as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking6,214 out of 12,080
Percentile48.6%

Yoseph Shaaltiel's 2013 compensation ranked 6,214th out of 12,080 executive pay records tracked by us this year.

Shaaltiel earned more than 48.6% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking457 out of 1,102
Percentile58.5%

In the industry group of Drugs, Shaaltiel's pay ranked 457th out of 1,102 executive pay records tracked by us in 2013.

Shaaltiel earned more than 58.5% of executives in this group.

Bonus$120,000
Option Awards$140,770
Salary$302,901
Stock Awards$429,927
Other$81,672
Total$1,075,270

Shaaltiel received $429.9K in stock awards, which accounts for 39.98% of total compensation.

Shaaltiel also received $120K in bonus, $140.8K in option awards, $302.9K in salary and $81.7K in other compensation.

2012

In 2012, Yoseph Shaaltiel earned a total compensation of $1.6M as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking4,279 out of 11,166
Percentile61.7%

Yoseph Shaaltiel's 2012 compensation ranked 4,279th out of 11,166 executive pay records tracked by us this year.

Shaaltiel earned more than 61.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking205 out of 863
Percentile76.2%

In the industry group of Drugs, Shaaltiel's pay ranked 205th out of 863 executive pay records tracked by us in 2012.

Shaaltiel earned more than 76.2% of executives in this group.

Bonus$225,000
Option Awards$608,826
Salary$283,655
Stock Awards$409,838
Other$67,257
Total$1,594,576

Shaaltiel received $608.8K in option awards, which accounts for 38.18% of total compensation.

Shaaltiel also received $225K in bonus, $283.7K in salary, $409.8K in stock awards and $67.3K in other compensation.

2011

In 2011, Yoseph Shaaltiel earned a total compensation of $413.2K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking8,328 out of 10,288
Percentile19.1%

Yoseph Shaaltiel's 2011 compensation ranked 8,328th out of 10,288 executive pay records tracked by us this year.

Shaaltiel earned more than 19.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking548 out of 716
Percentile23.5%

In the industry group of Drugs, Shaaltiel's pay ranked 548th out of 716 executive pay records tracked by us in 2011.

Shaaltiel earned more than 23.5% of executives in this group.

Option Awards$27,830
Salary$305,280
Other$80,063
Total$413,173

Shaaltiel received $305.3K in salary, which accounts for 73.89% of total compensation.

Shaaltiel also received $27.8K in option awards and $80.1K in other compensation.

2010

In 2010, Yoseph Shaaltiel earned a total compensation of $538.9K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking7,110 out of 9,812
Percentile27.5%

Yoseph Shaaltiel's 2010 compensation ranked 7,110th out of 9,812 executive pay records tracked by us this year.

Shaaltiel earned more than 27.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking427 out of 638
Percentile33.1%

In the industry group of Drugs, Shaaltiel's pay ranked 427th out of 638 executive pay records tracked by us in 2010.

Shaaltiel earned more than 33.1% of executives in this group.

Bonus$100,000
Option Awards$70,286
Salary$292,095
Other$76,491
Total$538,872

Shaaltiel received $292.1K in salary, which accounts for 54.20% of total compensation.

Shaaltiel also received $100K in bonus, $70.3K in option awards and $76.5K in other compensation.

2009

In 2009, Yoseph Shaaltiel earned a total compensation of $619.6K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking5,791 out of 9,079
Percentile36.2%

Yoseph Shaaltiel's 2009 compensation ranked 5,791st out of 9,079 executive pay records tracked by us this year.

Shaaltiel earned more than 36.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking309 out of 595
Percentile48.1%

In the industry group of Drugs, Shaaltiel's pay ranked 309th out of 595 executive pay records tracked by us in 2009.

Shaaltiel earned more than 48.1% of executives in this group.

Bonus$160,000
Option Awards$225,336
Salary$196,271
Other$37,981
Total$619,588

Shaaltiel received $225.3K in option awards, which accounts for 36.37% of total compensation.

Shaaltiel also received $160K in bonus, $196.3K in salary and $38K in other compensation.

2008

In 2008, Yoseph Shaaltiel earned a total compensation of $444.7K as Executive Vice President, Research and Development at Protalix BioTherapeutics.

Ranking6,316 out of 8,222
Percentile23.2%

Yoseph Shaaltiel's 2008 compensation ranked 6,316th out of 8,222 executive pay records tracked by us this year.

Shaaltiel earned more than 23.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking389 out of 558
Percentile30.3%

In the industry group of Drugs, Shaaltiel's pay ranked 389th out of 558 executive pay records tracked by us in 2008.

Shaaltiel earned more than 30.3% of executives in this group.

Option Awards$163,328
Salary$226,652
Other$54,704
Total$444,684

Shaaltiel received $226.7K in salary, which accounts for 50.97% of total compensation.

Shaaltiel also received $163.3K in option awards and $54.7K in other compensation.

2007

In 2007, Yoseph Shaaltiel earned a total compensation of $277.1K as Executive Vice President at Protalix BioTherapeutics.

Ranking6,639 out of 7,493
Percentile11.4%

Yoseph Shaaltiel's 2007 compensation ranked 6,639th out of 7,493 executive pay records tracked by us this year.

Shaaltiel earned more than 11.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking447 out of 494
Percentile9.5%

In the industry group of Drugs, Shaaltiel's pay ranked 447th out of 494 executive pay records tracked by us in 2007.

Shaaltiel earned more than 9.5% of executives in this group.

Bonus$50,000
Option Awards$2,420
Salary$177,297
Other$47,339
Total$277,056

Shaaltiel received $177.3K in salary, which accounts for 63.99% of total compensation.

Shaaltiel also received $50K in bonus, $2.4K in option awards and $47.3K in other compensation.

2006

In 2006, Yoseph Shaaltiel earned a total compensation of $250.8K as Executive Vice President at Protalix BioTherapeutics.

Ranking5,207 out of 5,899
Percentile11.7%

Yoseph Shaaltiel's 2006 compensation ranked 5,207th out of 5,899 executive pay records tracked by us this year.

Shaaltiel earned more than 11.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking385 out of 449
Percentile14.3%

In the industry group of Drugs, Shaaltiel's pay ranked 385th out of 449 executive pay records tracked by us in 2006.

Shaaltiel earned more than 14.3% of executives in this group.

Bonus$31,953
Option Awards$7,684
Salary$177,658
Other$33,521
Total$250,816

Shaaltiel received $177.7K in salary, which accounts for 70.83% of total compensation.

Shaaltiel also received $32K in bonus, $7.7K in option awards and $33.5K in other compensation.